Connect Biopharma (NASDAQ: CNTB) reported Q2 EPS of ($0.27), $1.89 better than the analyst estimate of ($2.16). Revenue for the quarter came in at $2.77 million versus the consensus estimate of $226.48 thousand.

For earnings history and earnings-related data on Connect Biopharma (CNTB) click here.